SciELO - Scientific Electronic Library Online

 
vol.39 número1Primera serie de biopsia transbronquial en CubaTratamiento de la hepatitis viral aguda c con interferón alfa 2b recombinante: Ensayo clínico índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Medicina

versión impresa ISSN 0034-7523versión On-line ISSN 1561-302X

Resumen

ARUS SOLER, Enrique et al. Tratamiento de la hepatitis crónica C con interferón alfa 2b recombinante: Ensayo clínico controlado aleatorizado. Rev cubana med [online]. 2000, vol.39, n.1, pp.12-20. ISSN 0034-7523.

A multicenter randomized controlled trial was conducted on 35 patients suffering from chronic hepatitis C. 19 of them were treated with interleukin (group I), whereas the other 16 made up the control group. Recombinant interleukin 2b alpha was used on a 9-month treatment scheme with doses that were gradually increased according to the biochemical response. A biochemical response of 57.9 % was obtained at the end of the treatment, while in the control group this response was of 12.5 %. The group of patients under treatment had a permanent biochemical response of 36.4 %. There was an improvement of the histological activity index of the study group, but in the control group this index was almost the same on the initial biopsy and the posttreatment biopsy. Tolerance to interleukin was good. It was concluded that the interleukin effect on the group of treated patinets was beneficial.

Palabras clave : HEPATITIS C, CHRONIC; RANDOMIZED CONTROLLED TRIALS; INTERFERONS..

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons